Abstract
Hip resurfacing arthroplasty is an option for people with advanced hip disease who would otherwise receive and are likely to outlive a conventional primary total hip replacement (THR), particularly for younger patients who wish to be reasonably active [1]. That guideline from the National Institute for Clinical Excellence (NICE), a statutory body in the United Kingdom, broadly sums up the indications in which a hip resurfacing device should be used.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
NICE. Available at http://guidance.nice.org.uk/TA44/guidance/pdf/English/download.dspx. Accessed August 2, 2007. NICE Guidelines ‘The clinical effectiveness and cost effectiveness of metal on metal hip resurfacing. Technology appraisal. June 2002’.
Daniel J, Pynsent PB, McMinn DJ. Metal-on-metal resurfacing of the hip in patients under the age of 55 years with osteoarthritis. J Bone Joint Surg Br 2004;86:177.
Schmalzried TP, Silva M, dela Rosa MA. Optimizing patient selection and outcomes with total hip resurfacing. Clin Orthop 2005;441:200.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag London Limited
About this chapter
Cite this chapter
Daniel, J., Pradhan, C., Ziaee, H. (2009). Patient Selection and Timing of Operation. In: McMinn, D.J.W. (eds) Modern Hip Resurfacing. Springer, London. https://doi.org/10.1007/978-1-84800-088-9_14
Download citation
DOI: https://doi.org/10.1007/978-1-84800-088-9_14
Publisher Name: Springer, London
Print ISBN: 978-1-84800-087-2
Online ISBN: 978-1-84800-088-9
eBook Packages: MedicineMedicine (R0)